Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.

North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.

In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.

The Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size was estimated at USD 2328.00 million in 2022 and is projected to reach USD 2079.45 million by 2029, exhibiting a CAGR of -1.60% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Chemotheraphy Induced Nausea and Vomitting CINV Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chemotheraphy Induced Nausea and Vomitting CINV Drugs market in any manner.

Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Heron Therapeutics

Merck

Eisai

Mundipharma

Qilu Pharma

Teva

Novartis

Roche

Mylan

Baxter

GSK

Helsinn

Southwest Pharma

Haisco

Sun Pharma

Market Segmentation (by Type)

5-HT3 Inhibitors

NK1 Inhibitors

Others

Market Segmentation (by Application)

Communication

Consumer Electronics

Aerospace and Defense

Car

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market

Overview of the regional outlook of the Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Chemotheraphy Induced Nausea and Vomitting CINV Drugs
1.2 Key Market Segments
1.2.1 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Segment by Type
1.2.2 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Competitive Landscape
3.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Manufacturers (2018-2023)
3.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales Sites, Area Served, Product Type
3.6 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Competitive Situation and Trends
3.6.1 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chemotheraphy Induced Nausea and Vomitting CINV Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Industry Chain Analysis
4.1 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales Market Share by Type (2018-2023)
6.3 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Price by Type (2018-2023)
7 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Sales by Application (2018-2023)
7.3 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales Growth Rate by Application (2018-2023)
8 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Segmentation by Region
8.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Region
8.1.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Region
8.1.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Heron Therapeutics
9.1.1 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.1.2 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.1.4 Heron Therapeutics Business Overview
9.1.5 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting CINV Drugs SWOT Analysis
9.1.6 Heron Therapeutics Recent Developments
9.2 Merck
9.2.1 Merck Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.2.2 Merck Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.2.3 Merck Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Chemotheraphy Induced Nausea and Vomitting CINV Drugs SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Eisai
9.3.1 Eisai Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.3.2 Eisai Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.3.4 Eisai Business Overview
9.3.5 Eisai Chemotheraphy Induced Nausea and Vomitting CINV Drugs SWOT Analysis
9.3.6 Eisai Recent Developments
9.4 Mundipharma
9.4.1 Mundipharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.4.2 Mundipharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.4.4 Mundipharma Business Overview
9.4.5 Mundipharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs SWOT Analysis
9.4.6 Mundipharma Recent Developments
9.5 Qilu Pharma
9.5.1 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.5.2 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.5.4 Qilu Pharma Business Overview
9.5.5 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs SWOT Analysis
9.5.6 Qilu Pharma Recent Developments
9.6 Teva
9.6.1 Teva Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.6.2 Teva Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.6.3 Teva Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.6.4 Teva Business Overview
9.6.5 Teva Recent Developments
9.7 Novartis
9.7.1 Novartis Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.7.2 Novartis Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Roche
9.8.1 Roche Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.8.2 Roche Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.8.3 Roche Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.8.4 Roche Business Overview
9.8.5 Roche Recent Developments
9.9 Mylan
9.9.1 Mylan Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.9.2 Mylan Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.9.4 Mylan Business Overview
9.9.5 Mylan Recent Developments
9.10 Baxter
9.10.1 Baxter Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.10.2 Baxter Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.10.4 Baxter Business Overview
9.10.5 Baxter Recent Developments
9.11 GSK
9.11.1 GSK Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.11.2 GSK Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.11.3 GSK Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.11.4 GSK Business Overview
9.11.5 GSK Recent Developments
9.12 Helsinn
9.12.1 Helsinn Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.12.4 Helsinn Business Overview
9.12.5 Helsinn Recent Developments
9.13 Southwest Pharma
9.13.1 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.13.4 Southwest Pharma Business Overview
9.13.5 Southwest Pharma Recent Developments
9.14 Haisco
9.14.1 Haisco Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.14.4 Haisco Business Overview
9.14.5 Haisco Recent Developments
9.15 Sun Pharma
9.15.1 Sun Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Basic Information
9.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Overview
9.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting CINV Drugs Product Market Performance
9.15.4 Sun Pharma Business Overview
9.15.5 Sun Pharma Recent Developments
10 Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Forecast by Region
10.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size Forecast
10.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size Forecast by Region
10.2.4 South America Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chemotheraphy Induced Nausea and Vomitting CINV Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Chemotheraphy Induced Nausea and Vomitting CINV Drugs by Type (2024-2029)
11.1.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Chemotheraphy Induced Nausea and Vomitting CINV Drugs by Type (2024-2029)
11.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Sales (K MT) Forecast by Application
11.2.2 Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings